Who owns EyePoint, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of EYPT from SEC Form 13F filings across 188 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 188 institutions disclosed 92.8M shares of EyePoint, Inc. worth $1.33B — about 107.3% of shares outstanding; the largest disclosed holder is MONTANOVA CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
188
13F holders
$1.33B
value, 2026 filers
107.3%
of shares outstanding (92.8M sh)
27
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of EYPT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 8.3M | $118.6M | 2.2% | 9.6% | 0.0% |
| 2 | BlackRock, Inc. | 7.5M | $106.7M | 0.0% | 8.6% | +4.0% |
| 3 | Cormorant Asset Management, LP | 7.0M | $100.1M | 5.1% | 8.1% | -15.3% |
| 4 | FEDERATED HERMES, INC. | 5.7M | $81.2M | 0.1% | 6.6% | +0.2% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.8M | $69.0M | 0.1% | 5.6% | +46.3% |
| 6 | FRANKLIN RESOURCES INC | 4.8M | $68.7M | 0.0% | 5.6% | -4.8% |
| 7 | Commodore Capital LP | 4.6M | $65.8M | 3.9% | 5.3% | +62.8% |
| 8 | Jupiter Topco LLCNEW | 3.8M | $53.9M | 0.0% | 4.4% | new |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 3.6M | $51.9M | 0.0% | 4.2% | +2.0% |
| 10 | Paradigm Biocapital Advisors LP | 2.9M | $41.3M | 0.8% | 3.3% | -8.0% |
| 11 | STATE STREET CORP | 2.4M | $33.7M | 0.0% | 2.7% | +12.4% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $29.5M | 0.0% | 2.4% | +4.0% |
| 13 | Aberdeen Group plc | 2.0M | $28.7M | 0.0% | 2.3% | +15.6% |
| 14 | CITADEL ADVISORS LLC | 2.0M | $28.3M | 0.0% | 2.3% | +3.8% |
| 15 | Balyasny Asset Management L.P. | 1.8M | $25.9M | 0.0% | 2.1% | +26.0% |
| 16 | Parkman Healthcare Partners LLC | 1.3M | $18.4M | 1.9% | 1.5% | -4.9% |
| 17 | EVENTIDE ASSET MANAGEMENT, LLC | 1.2M | $17.8M | 0.2% | 1.4% | 0.0% |
| 18 | TWO SIGMA INVESTMENTS, LP | 1.2M | $16.9M | 0.0% | 1.4% | +174.5% |
| 19 | Essex Woodlands Management, Inc. | 1.1M | $15.5M | 6.1% | 1.3% | 0.0% |
| 20 | ORBIMED ADVISORS LLC | 1.1M | $15.3M | 0.3% | 1.2% | 0.0% |
| 21 | 5AM Venture Management, LLC | 1.1M | $15.0M | 5.2% | 1.2% | 0.0% |
| 22 | Rosalind Advisors, Inc. | 988,230 | $14.1M | 5.2% | 1.1% | -4.7% |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | 971,014 | $13.9M | 0.0% | 1.1% | +22.3% |
| 24 | AMERIPRISE FINANCIAL INC | 848,410 | $12.1M | 0.0% | 1% | +100.4% |
| 25 | DIMENSIONAL FUND ADVISORS LP | 841,746 | $12.0M | 0.0% | 1% | +109.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.